PE-backed Canopy Biosciences buys Zellkraftwerk
Canopy Biosciences, which is backed by Ampersand Capital Partners, has acquired Zellkraftwerk, a German provider of cellular biomarkers. No financial terms were disclosed.
29 April 2019•4 mins read
Canopy Biosciences, which is backed by Ampersand Capital Partners, has acquired Zellkraftwerk, a German provider of cellular biomarkers. No financial terms were disclosed.
GrowthCurve Capital takes majority stake in medication access platform TailorMed
8 hours ago · 1 min read
OpenGate Capital completes carve-out of Maersk Training from Maersk
10 hours ago · 1 min read
Stonepeak completes acquisition of 65% Castrol stake from BP
11 hours ago · 1 min read
Livingbridge backs launch of accounting group Apteus after seven acquisitions
13 hours ago · 2 mins read
DPE-backed CirQono acquires Saxony demolition firm ORA in add-on deal
16 hours ago · 2 mins read
Charterhouse agrees to sell Vermeg stake to Advent, with ADIA co-investing
16 hours ago · 2 mins read
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
30 October 2026 · 2 mins read
